The Japanese government is seeking to strengthen the country’s global biotech position amid U.S. drug pricing changes and ...

Researchers from Imperial College London and collaborating institutions aimed to discover inhibitors of the ciprofloxacin-induced SOS response, which promotes DNA repair, mutagenesis and emergence of ...

Corticotropin-releasing factor receptor 2 (CRF2R) is expressed across multiple metabolically relevant organs, including adipose tissue, skeletal muscle, the heart and kidneys, making it an attractive ...

For decades, cell therapy has been viewed as one of the most promising routes to a functional cure for type 1 diabetes (T1D).

The Royal Swedish Academy of Sciences has awarded the 2026 Nobel Prize in Chemistry to Henri Kagan and Kenso Soai for ...

Kymathera has closed an $80 million series B financing to support development of next-generation precision medicines for ...

Shenzhen Salubris Pharmaceuticals Co. Ltd. has described new tetrahydroquinoline compounds reported to be useful for the treatment of inflammatory bowel disease and inflammatory disorders.

Cristae Therapeutics Ltd. has divulged new 3-aza steroids acting as reactive oxygen species (ROS) production inhibitors potentially useful for the treatment of neurodegeneration and neuromuscular ...

Just six months after paying $2.5 billion to establish a commercial rare-disease platform around ALS therapy Radicava (edaravone), Shionogi & Co. Ltd. is doubling down with a planned $2 billion ...

Partners Abbvie Inc. and Genmab A/S may be able to file earlier than expected to bring the T-cell engaging bispecific antibody Epkinly (epcoritamab) into a broader diffuse large B-cell lymphoma (DLBCL ...

One of the players in what was shaping up as a three-way battle took a hit when Arrivent Biopharma Inc. rolled out results ...

Becton, Dickinson and Co. (BD) plans to invest $19 billion in the U.S. over several years as part of a deal with the U.S.